Targeting the complement cascade: novel treatments coming down the pike - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue Kidney International Année : 2016

Targeting the complement cascade: novel treatments coming down the pike


The complement cascade is a vital component of both the innate and adaptive immune systems. Complement activation also contributes to the pathogenesis of many diseases, however, and the kidney is particularly susceptible to complement-mediated injury. Drugs that block complement activation can rapidly reduce tissue inflammation and also attenuate the adaptive immune response to foreign and tissue antigens. Eculizumab is a monoclonal antibody that prevents the cleavage of C5. It has been approved for the treatment of atypical hemolytic uremic syndrome, and it has been used in selected patients with other kidney diseases. Many additional drugs are also in development for blocking the complement cascade, including new monoclonal antibodies, recombinant proteins, small molecules, and small interfering RNA agents. Validation of these new drugs as effective treatments for kidney diseases faces several challenges. Many complement-mediated kidney diseases are rare, so it is not feasible to test all of the new drugs in numerous different rare diseases. The onset and course of the diseases are heterogeneous; many of these diseases also carry a lifelong risk of recurrence, and it is not clear how long complement inhibition must be maintained. In spite of these challenges, new therapeutic options for targeting the complement system will likely become available in the near future and may prove useful for treating patients with kidney disease.
Fichier principal
Vignette du fichier
IRMB 33_P50_Targeting the Complement Cascade Novel Treatments Coming down the Pike_nihms787264.pdf (750.55 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-01838465 , version 1 (17-03-2021)



Joshua Thurman, Moglie Le Quintrec. Targeting the complement cascade: novel treatments coming down the pike. Kidney International, 2016, 90 (4), pp.746-752. ⟨10.1016/j.kint.2016.04.018⟩. ⟨hal-01838465⟩
87 Consultations
63 Téléchargements



Gmail Facebook X LinkedIn More